 Greenwich LifeSciences Inc NASDAQ: GLSI has announced the abstract results of the final 5-year immune response data of the Phase 2b trial at the 2021 AACR Annual Meeting. The company plans to publish the poster, the abstract, and an audio recording tomorrow in a joint press release. 